MedPath

Labor Protocol Study

Terminated
Conditions
Induced; Birth
Vaginal Delivery
Labor
Interventions
Device: Cervical Foley Balloon
Registration Number
NCT04004845
Lead Sponsor
Montefiore Medical Center
Brief Summary

The goal of this study is to see if there is a better way to induce labor.

Detailed Description

This is quasi-experimental prospective cohort study with historical control to examine the efficacy of a new labor induction bundle. The prospective cohort will consist of all eligible nulliparous and multiparous patients admitted for induction; the historical control group will consist of all eligible nulliparous and multiparous patients admitted for induction between August 2019 and February 2020. Patients who are part of the prospective cohort who do not consent to the labor bundle due to personal or physician preferences will be included in secondary analyses as a contemporary control group, however the sample size of this group will not be determined in advance.

Objective: To assess if implementation of an evidence-based labor induction bundle will increase the rate of vaginal delivery within 24 hours.

Hypothesis: Implementation of a labor induction bundle would result in a 30% increase in the rate of vaginal delivery within 24 hours.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
66
Inclusion Criteria
  1. Singleton pregnancy
  2. Cephalic presentation
  3. Gestational age 36 weeks 6 days- 42 weeks 0 days at initiation of induction of labor
  4. Age 18 and over
Exclusion Criteria
  1. Preterm (less than 36 weeks 6 days) at initiation of induction of labor
  2. Non-cephalic presentation
  3. Major fetal anomalies or intrauterine fetal death
  4. Bishop score more than 6 at initiation of induction of labor
  5. Any contraindication to any agents in the induction protocol (i.e. prior cesarean delivery or myomectomy, three or more contractions per ten minute period averaged over 30 minutes at the initiation of induction of labor, low lying placenta).
  6. Any contraindication to vaginal delivery
  7. Latex allergic

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pregnant womenCytotecWe are including only women who are age 18 or over, who have a single baby (not twins), with the baby's head down, and are between 36 weeks 6 days and 42 weeks 0 days of pregnancy.
Pregnant womenCervical Foley BalloonWe are including only women who are age 18 or over, who have a single baby (not twins), with the baby's head down, and are between 36 weeks 6 days and 42 weeks 0 days of pregnancy.
Pregnant womenoxytocinWe are including only women who are age 18 or over, who have a single baby (not twins), with the baby's head down, and are between 36 weeks 6 days and 42 weeks 0 days of pregnancy.
Primary Outcome Measures
NameTimeMethod
Percentage of Vaginal DeliveriesWithin 24 hours

Percent vaginal delivery within 24 hours of initiation of labor induction

Secondary Outcome Measures
NameTimeMethod
Incidence of transfusion of blood productsWithin 7 days
Incidence of Neonatal 5-minute APGAR score <7Within 4 days
Percent of vaginal delivery within 12 hours of initiating inductionWithin 12 hours
Percent of deliveries (vaginal or cesarean) within 12 hours of initiating inductionWithin 12 hours
Rate of vaginal deliveryWithin 4 days
Rate of cesarean deliveryWithin 4 days
Rate of operative vaginal deliveryWithin 4 days
For patients undergoing cesarean delivery, rate of each indication for cesarean deliveryWithin 4 days
Incidence of chorioamnionitisWithin 4 days
Number of vaginal examsWithin 4 days

mean, median

Incidence of spontaneous internal version to non-cephalic presentationWithin 4 days
Incidence of umbilical cord prolapseWithin 4 days
Incidence of postpartum hemorrhageWithin 7 days
Percent of deliveries (vaginal or cesarean) within 24 hours of initiating inductionWithin 24 hours
Incidence of Umbilical cord pH < 7, <7.1, <7.2Within 4 days
Incidence of Neonatal NICU admissionWithin 7 days
Patient satisfaction with induction and delivery process measured on a scale of 1-10 - immediateDuring delivery hospitalization

Will analyze mean, median. Scale 1, 2, 3, 4, 5, 6, 7, 8, 9, 10. Minimum score 1, Maximum score 10. A score of 1 is considered a worse outcome (completely dissatisfied) and 10 is considered a better outcome (completely satisfied). A score of 5 is neutral.

Incidence of shoulder dystociaWithin 4 days
Incidence of birth injuries (eg. brachial plexus injuries, musculoskeletal injuries, etc).Within 7 days
Number of attending physicians managing induction of laborWithin 4 days
Number of attending-to-attending hand-off'sWithin 4 days
Number of resident-to-resident team hand-off'sWithin 4 days

Trial Locations

Locations (1)

Montefiore Medical Center Weiler Division / Albert Einstein College of Medicine

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath